Biotech company, Biocon will see two crucial inspections later this month and in early April. Company‘s manufacturing sites will come up for inspections by the European medicines agency later this month and next will be an inspection by the US FDA.
first published: Mar 2, 2017 01:45 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell
Live: Will Nifty's weakness continue for the second straight day? | Opening Bell
A money superpower you have in your 20s, not in 40s
Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
